TRICITRATES - POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE
Navigation: NDC > Supplier starting with: P > PHARMACEUTICAL ASSOCIATES, INC.| Field | Value |
|---|---|
| NDC Code: | 0121-0677 |
| Proprietary Name: | TRICITRATES |
| Suffix: | |
| Non-Proprietary Name: | POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Dosage Form: | SOLUTION |
| Method: | ORAL |
| Original Marketing Date: | 25-05-2005 |
| Category Name: | UNAPPROVED DRUG OTHER |
| Application Number: | |
| Labeler: | PHARMACEUTICAL ASSOCIATES, INC. |
| Substance Name: | CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE |
| Active Numerator Strength: | 334; 550; 500 |
| Active Ingredient Unit: | mg/5mL; mg/5mL; mg/5mL |
| Pharm Classes: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |